Accumulating evidence has shown that the impaired insulin signaling pathway, together with inflammatory responses, promotes hepatic lipid biosynthesis and steatosis, which in turn contribute to chronic hepatic inflammation and insulin resistance (Wang et al., 2016). This evidence concerns the gene INS and Insulin resistance.